Impact promotes Alzheimer disease drug trial

Impact promotes Alzheimer disease drug trial

Impact promotes Alzheimer drug trial NJ-based, minority woman-owned firm tapped to promote SUVN-502 drug trial   East Orange, N.J., Jan. 10, 2017—  Impact Consulting Enterprises, a strategic communication, marketing and public relations firm based in East Orange, N.J., has signed a deal with Suven, Inc., a Monmouth Junction, N.J.-based pharmaceutical company, to publicize Suven’s launch of a…